These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28748919)

  • 1. Changing concepts in hypertension management.
    Gudsoorkar PS; Tobe SW
    J Hum Hypertens; 2017 Dec; 31(12):763-767. PubMed ID: 28748919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thresholds and Targets for Hypertension Management in Adults With Type 2 Diabetes Should Remain at 130/80 mmHg: What's the Evidence?
    Shahi N; Tobe SW
    Can J Diabetes; 2018 Apr; 42(2):166-172. PubMed ID: 29273294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the SPRINT Trial on Hypertension Management.
    Ghazi L; Oparil S
    Annu Rev Med; 2018 Jan; 69():81-95. PubMed ID: 29414255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of new clinical trials on recent guidelines on hypertension management.
    Mancia G; Grassi G
    Ann Med; 2011 Mar; 43(2):124-32. PubMed ID: 21254905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches in the treatment of hypertension.
    Oparil S; Schmieder RE
    Circ Res; 2015 Mar; 116(6):1074-95. PubMed ID: 25767291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.
    Zanchetti A; Thomopoulos C; Parati G
    Circ Res; 2015 Mar; 116(6):1058-73. PubMed ID: 25767290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which Target Blood Pressure in Year 2018? Evidence from Recent Clinical Trials.
    Heimark S; Mariampillai JE; Narkiewicz K; Nilsson PM; Kjeldsen SE
    High Blood Press Cardiovasc Prev; 2018 Jun; 25(2):151-158. PubMed ID: 29663195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Khan NA; Hemmelgarn B; Padwal R; Larochelle P; Mahon JL; Lewanczuk RZ; McAlister FA; Rabkin SW; Hill MD; Feldman RD; Schiffrin EL; Campbell NR; Logan AG; Arnold M; Moe G; Campbell TS; Milot A; Stone JA; Jones C; Leiter LA; Ogilvie RI; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; Burns KD; Ruzicka M; deChamplain J; Pylypchuk G; Gledhill N; Petrella R; Boulanger JM; Trudeau L; Hegele RA; Woo V; McFarlane P; Touyz RM; Tobe SW;
    Can J Cardiol; 2007 May; 23(7):539-50. PubMed ID: 17534460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SPRINT and the HOPE-3 Trial in the Context of Other Blood Pressure-Lowering Trials.
    Yusuf S; Lonn E
    JAMA Cardiol; 2016 Nov; 1(8):857-858. PubMed ID: 27602555
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute and Chronic Hypertension: What Clinicians Need to Know for Diagnosis and Management.
    Rivera SL; Martin J; Landry J
    Crit Care Nurs Clin North Am; 2019 Mar; 31(1):97-108. PubMed ID: 30736939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?
    Bhatt H; Ghazi L; Calhoun D; Oparil S
    Curr Cardiol Rep; 2016 Oct; 18(10):98. PubMed ID: 27566331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistant Hypertension: Insights on Evaluation and Management in the Post-SPRINT (Systolic Blood Pressure Intervention Trial) Era.
    Townsend RR; Epstein M
    Hypertension; 2016 Nov; 68(5):1073-1080. PubMed ID: 27600177
    [No Abstract]   [Full Text] [Related]  

  • 17. Management plans for populations with normal-to-hypertensive blood pressures: risks and benefits of antihypertensive drug treatment in populations previously defined as having high-normal blood pressure.
    Park S
    Korean J Intern Med; 2019 Jan; 34(1):44-49. PubMed ID: 30612417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should blood pressure goal be individualized in hypertensive patients?
    Yannoutsos A; Kheder-Elfekih R; Halimi JM; Safar ME; Blacher J
    Pharmacol Res; 2017 Apr; 118():53-63. PubMed ID: 27919826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the effectiveness of hypertension management be improved?
    Ruilope LM
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):689-95. PubMed ID: 23750678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in the Management of Hypertension in Older Populations.
    Pont L; Alhawassi T
    Adv Exp Med Biol; 2017; 956():167-180. PubMed ID: 27815929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.